The first report in the United Kingdom of Marek's disease (MD), or fowl paralysis as it was then called, was made at a meeting of the Royal Society of Medicine by Galloway in 1929. The principle features of the disease are lymphoma formation and demyelination in peripheral nerves (Payne et al. 1976) . For more than 50 years MD was the subject of a voluminous literature in which was argued its aetiology, transmissibility, the nature of the lesions and its relationship to other leukotic diseases of the fowl.
Although MD was always one ofthe commonest of poultry diseases, pressures to understand and control it were heightened during the 1960s by the appearance throughout the world of a highly virulent form of the disease characterized by extensive lymphoma formation and a mortality rate of up to 80% of affected flocks. The outcome of these pressures was that in the space of eight years, from 1962-1970, the disease was transformed from one ofunknown cause to one in which the cause was known and a commercial vaccine was developed for its successful control (Nazerian et al. 1976) .
Several main events occurred during this period: first, the experimental transmission of MD by inoculation of newborn susceptible chicks with live blood or tumour cells from affected birds; secondly, growth of the MD agent in tissue culture following inoculation of live cells and demonstration that it was a herpesvirus; thirdly, attenuation of MD virus by continuous passage in tissue culture and demonstration that the attenuated virus could be used to produce immunity against virulent virus, thus providing a vaccine which. was shortly afterwards shown to be effective in the field; finally, isolation of a herpesvirus from turkeys (HVT) which was antigenically related to MDV but nonpathogenic in chickens (and turkeys), and demonstration that this was also able to immunize against MD. This HVT vaccine is now produced commercially and is used on a world-wide basis to prevent MD.
Agricultural needs were the prime moving force for MD research (Purchase 1977) , but there has been another important area of significance for research on MD, namely the biomedical implications of MD as a model system in viral oncology and in certain other areas of pathology. IBased on Dr L N Payne's Presidential Address to Section of Comparative Medicine, 18 October 1978 A horizontally-transmitted tumour virus MD is an infectious and contagious disease with neoplasia as one ofthe possible outcomes. Vertical transmission of the virus through the embryo does not occur. As an epidemiological model, it is one of the simplest types and would appear to have little or no relevance to at least the great majority of tumours in man, which show no evidence of contagiousness. Nevertheless, there is a small group of neoplastic disorders in humans for which a viral aetiology is at least a possibility. MD was the first lymphomatous disease to be shown unequivocally to be caused by a herpesvirus, and it therefore provides a model for certain herpesvirus-associated neoplasms in man. The closest similarity is undoubtedly to Burkitt's lymphoma (BL), which is generally believed to be caused by the Epstein-Barr virus (EBV), followed by nasopharyngeal carcinoma (NPC), probably also caused by this virus.
Although at times MD appears to be a highly contagious disease resulting in a high incidence of tumours, at others the incidence of clinical disease can be very low even when all birds in the flock are infected with MDV. This latter type of association is of comparative interest because it shows that an uncommon tumour can be caused by a common, widely prevalent virus.
A number of factorsviral, host and environmentalthat influence the outcome of infection by MDV have been recognized. Strains of MDV varygreatly in oncogenicity, from highly oncogenic to nononcogenic. Although this is partly a property of the viral genome, oncogenicity is not entirely so dependent, for Calnek et al. (1977) have recently shown that low virulence strains of MDV express tumour-producing potential when injected into embryonic or immunosuppressed chickens. This illustrates the fact that viruses not normally considered oncogenic can be so in the right host environment.
Normally nononcogenic strains of MDV appear to be important in the epidemiology of clinical MD because they may act as natural immunizing viruses, providing protection against later challenge and explaining why different groups of birds of apparently similar infective status develop different incidences of tumours.
The genotype of the chicken is one of the major factors which influences the outcome of infection by MDV. Recently, much attention has been focused on the effect on MD of the B blood group system, which is associated with the major histocompatibility complex. One allele in particular, 06 1979 The Royal Society of Medicine 0141-0768/79/090635--04/$01.00/0 B21, is strongly correlated with resistance to MD. The immunogenetics of MD is attracting increasing attention and may throw light on why one individual, and not another, develops a lymphoma in response to infection.
An environmental factor which appears to influence MD but as yet has only been touched upon by research workers is that of stress. Much anecdotal evidence suggests that stressing factors increase the incidence of MD, and evidence exists that birds which react strongly to stress as measured by corticosterone production are highly susceptible to MD. Great opportunities exist in this unexplored field in MD research which may throw light on the little understood possibility that stress may influence neoplastic disease in man.
A lymphomagenic herpesvirus MDV is of value for studying virus-cell relationships that lead to neoplasia, again with particular reference to EBV. Methodologically, research on MD has been complementary to that on BL. Research into animal disease has the great advantage over research into diseases of man in that the direct test of causal relationships between possible aetiological agents and the disease can be made by transmission experiments. In MD such experiments rapidly led to the recognition of the MD herpesvirus as the cause of MD and paved the way for the development of vaccines. In man, for obvious reasons, aetiological relationships must often be built up circumstantially by indirect methods. In BL research, this has led to enormous bodies of information in two areas: first, the establishment of cell lines derived in culture from BL, and the study ofthe relationship between EBV and these cells; and secondly, serological associations between EBV infection and disease. Opportunities for direct experimentation in MD has, until recently, resulted in neglect of these approaches. However, MD tumour cell lines have become necessary to the understanding of the virus-cell interaction which leads to neoplasia, and more than twelve lymphoblastoid cell lines have now been established. Primary lymphomas consist of a mixture of T and B cells, and a minority of the tumour cells are believed to be neoplastically transformed on the basis of carrying a putative tumour-specific antigen. The other cells may be immunologically reactive cells. All lines so far isolated consist of T cells, and this cell is regarded as the neoplastic element in MD lymphomas. This contrasts with the B cell tumour lines associated with BL and EBV. The successful transformation of chicken T cells by MDV in vitro has yet to be accomplished, and this must be regarded as one of the most important next steps.
A question that is receiving increasing attention the extent to which this represents differences in proportions of neoplastic and non-neoplastic cells in the lymphomas, differences in virus production, or differences in nonproductive genome, is still unknown. One interesting finding is that within an individual chicken, lymphomas derived from different locations are similar in viral genome content, indicating some stable yirus-host relationship.
Studies on the antigenic expression of MDV in cell lines has lagged behind similar studies with EBV and BL lines: in MD only early antigen and some other poorly defined viral antigens and a putative tumour-specific antigen have been detected. This latter antigen, designated MATSA (Marek's disease tumour surface antigen), is currently the subject of much study. MATSA is of especial interest for two reasons: first, as a marker for neoplastic transformation, for MATSA is present on all cells of the cell lines and on about 10-30% of lymphoma cells; secondly, MATSA may be important in provoking antitumour immunity in MDV-infected birds.
The possible relationship between MDV and exogenous or endogenous RNA tumour viruses in the aetiology oflymphomas has attracted attention. Interest in this was stimulated by the oncogene hypothesis of Huebner & Todaro (1969) , which raised the possibility that various carcinogens might be oncogenic by activating an RNA tumour virus, and more specifically by finding that oncornavirus particles and related DNA sequences were present in BL cells. The current belief is that while exogenous oncornavirus is not essential for formation of lymphomas by MDV, there is some enhancement of lesions. With regard to endogenous RNA virus, while MD lymphomas can be induced in chickens with no biological expression ofendogenous virus, there may be enhancement of expression of gs-antigens. Whether this enhancement of endogenous virus is essential for oncogenesis, or merely an epiphenomenon, remains to be seen.
Vaccinal control ofa virus-induced tumour
In many countries throughout the world virtually every newly-hatched chick (with the common exception of short-lived broilers) is vaccinated with live vaccine virus. As a consequence of vaccination, the incidence ofMD has been reduced by about 90 %. MD vaccination is of interest from the comparative viewpoint since it is the first time that a common neoplastic disease has been controlled with a commercial vaccine. In spite of the success of the vaccine, there is still no clear understanding of how it works. MD vaccinal immunity is unusual in that although tumour formation is prevented, the vaccinated bird, once infected with MDV, continues to carry the virulent virus. For some years workers have been interested in the nature of the virusand tumour-assgciated antigens which might be involved in stimulating immunity, and in the nature of the chicken's responses to these antigens. A 'two-step' hypothesis of vaccinal immunity has been produced which suggests there are two components to immunity, possibly sequential, the first directed against viral antigens, and the second directed against transformed lymphoid cells, eliminating the tumour. This hypothesis was based essentially on the observation that either inactivated viral antigens or inactivated tumour antigens would provide immunity to MD, apparently by different mechanisms.
The question of the relative roles of humoral and cell-mediated immunity in vaccinated birds is equally complex and unsettled. Various antiviral antibodies have been detected, as have anti-MATSA antibodies in hyperimmunized chickens, but not in normal infected chickens. The ability to vaccinate agammaglobulinaemic chickens suggests that cell-mediated immunity might be important. Ross (1977) has recently described a Tcell-mediated MDV plaque reduction test and the role of this is currently being studied. Antitumour cell-mediated immunity has also been described. A great deal of systematic study is now required to clarify the roleofthese and other immune responses in vaccinal immunity.
From the comparative aspect, work with MD has shown that it is possible to vaccinate against an herpesvirus-induced lymphoma, and this is of obvious relevance for EBV and BL. Indeed, proposals are now in hand for the development of a vaccine against EBV-related diseases, namely BL, NPC and infectious mononucleosis. There is understandable reluctance to develop a vaccine which might contain nucleic acids, and one based on purified antigens is likely, for which a precedent has been provided by the MD system.
An autoimmune demyelinating disease
When Marek first described fowl paralysis he termed it a polyneuritis. Later workers observed lymphomatous features in the peripheral nerve lesions and called the disease neurolymphomatosis. This argument about whether the disease was inflammatory or neoplastic, whether both types of lesion occur and, ifso, which comes first, continued for many years. Payne & Biggs (1967) presented evidence that the inflammatory lesion was a sequel to the neoplastic lesion.
Lawn & Payne (1979) have recently conducted a chronological ultrastructural study of the nerve lesion in MD. At no time were herpesvirus particles seen in any neural tissue, and the stimulus for the first cell infiltration into the-nerves, by macrophage-like cells at 5 days after infection, remains unknown. Shortly after, lymphocytes appeared and increased to give rise to areas of lymphoproliferation and infiltration typical of MD. A striking feature was the abrupt onset of symptoms and demyelination in the fourth week after infection, and within areas of lymphoid infiltration, supporting the idea that the demyelination is a consequence of the lymphoid lesion and not its cause. This demyelination was associated with the infiltration ofthe basement membrane ofthe Schwann cells by macrophages and lymphocytes, with sparing of axons. Later repair and remyelination was observed, with a reduction in infiltrating lymphoid cells and the presence of oedema consistent with the inflammatory lesion.
It appears that at some stage during the development of nerve infiltration, but later rather than earlier, autosensitization to myelin occurs, which sets in train a progressive cell-mediated primary demyelination. Superimposed on these changes is a lymphomatous proliferation, which may be progressive or which may regress. Support for the idea of autoimmunity to myelin is provided by recent work of Schmahl et al. (1975) who demonstrated a delayed hypersensitivity reaction against normal myelin by skin tests, and by Lampert et al. (1977) who demonstrated the close ultrastructural similarities between the demyelination in MD and that occurring in experimental allergic neuritis (EAN) induced by inoculation of normal myelin.
Outstanding,from the comparative viewpoint is the similarity between the lesions of the Guillain-Barre syndrome (GBS) in man and those of MD and EAN. There are also aetiological similarities between GBS and MD: a variety of stimuli will initiate GBS, but notable among these are herpesvirus infections including EBV, zoster-varicella, cytomegalovirus and herpes simplex. Furthermore, GBS has been observed to follow infectious mononucleosis and other lymphoproliferative disorders. Studies on MD neuropathy may therefore be helpful in determining the pathogenesis ofGBS, and the MD model could also be useful in therapeutic studies.
Viral involvement in atherosclerosis
Recent events indicate that MD has not yet exhausted its possibilities of surprising us. Fabricantetal. (1978) have reported that MDV infection can lead to occlusive atherosclerosis of large muscular arteries in both hyper-and normocholesterolaemic chickens, with lesions resembling those of chronic atherosclerosis in human arteries. Grossly visible, often occlusive, atherosclerosis was seen in MDV-infected chickens with either normal or increased blood cholesterol levels and this gross change was absent in controls. Microscopically, lesions were present in the majority of MDV-infected birds fed cholesterol, but in few fed cholesterol alone.
These Antimicrobial defence mechas In lower anjnals1
Despite the fact that we are able to overcome most of the infections that afflict us and that immunization procedures have been extremely successful against smallpox and a number of other diseases, we still know remarkably little about the actual mechanisms ofimmunity against microorganisms. The mouse has contributed much to our understanding of the immune response as a whole and gradually our knowledge of the delicate interplay between cell-mediated and humoral immunity, macrophages and lymphocytes and sets and subsets of lymphocytes is becoming clearer. The immune response of mammals is extremely complex and this complexity continually frustrates attempts to come to terms with the actual nature of antimicrobial defence mechanisms. For some diseases, such as influenza, we already possess a wealth of knowledge; for others, including the most important diseases in the tropics, we are little further forward than we were before the immunological revolution began. It is tempting, therefore, to turn to less complex immune systems as sources of information and in a symposium on antimicrobial defence mechanisms published in this issue (page 683) the responses of invertebrates, amphibians and birds are compared with those of man.
Much has been written recently on immunity in lower animals (Bulla & Cheng 1977 , Cooper 1977a , Cooper & Dayton 1977 , Manning & Turner 1976 , Marchalonis 1977 , Solomon & Horton 1977 . It is generally held that the immune response evolved first as a cell-mediated one and later in a humoral form. There is little doubt that the lowest vertebrates possess a fully effective cell-mediated response to skin grafts and exhibit delayed hypersensitivity reactions. Many researchers have looked for evidence of cell-mediated immunity of the vertebrate type in invertebrates (Cooper 1977b) but the evidence for its existence is largely circumstantial and unconvincing. Cell-mediated immunity, therefore, probably evolved with the first vertebrates and seems to have remained substantially unchanged ever since (Wright & Cooper 1976) . There is less argument about humoral immunity in invertebrates, for although these animals possess a variety of substances that may be antimicrobial in nature these do not include immunoglobulins (Bulla & Cheng 1977 , Hildemann 1974 , Parish 1977 . Immunoglobulins do not occur in lampreys, the most primitive vertebrates alive today, but do occur in all higher vertebrates from hagfish to mammals. In the most primitive forms, IgM is the only immunoglobulin with antibody activity. In the hagfish and cartilaginous fish it takes the pentameric form characteristic of mammals but in the bony fish it is tetrameric. In all these fish, monomeric forms of IgM occur and, unlike the monomer of mammalian IgM, these have antibody activity. IgG appears as a second class of immunoglobulin in the terrestrial line which includes amphibians, reptiles and birds as well as mammals. A fourth class of immunoglob-I Based on paper read to Section of Comparative Medicine, 15 March 1978 0141-0768/79/090638-02/$01.00/0
